FIELD: medicine; pharmacology.
SUBSTANCE: composition has photochemotherapeutic protoporphyrine agent combined with photosensitizer agents localizable in vascular stroma and at least one substance promoting penetration through surface and optionally one or more chelating agents. The composition is usable for treating disease or anomalies responding to PDT manifesting synergic therapeutic properties.
EFFECT: increased photochemotherapeutic action; inhibited tumor growth. 20 cl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| 5-AMINOLEVULINIC ACID ESTERS AS PHOTOSENSIBILIZING AGENTS IN PHOTOCHEMOTHERAPY | 1996 |
|
RU2191010C2 |
| 5-AMINOLEVULINIC ACID ESTERS AS PHOTOSENSITIVE AGENTS IN PHOTOCHEMOTHERAPY | 2001 |
|
RU2246483C2 |
| COMPOUND | 2002 |
|
RU2323940C2 |
| METHOD FOR PRODUCING CHLORINES AND PHARMACEUTICAL APPLICATIONS THEREOF | 2009 |
|
RU2513483C2 |
| USING 5-AMINOLEVULINIC ACID AND DERIVATIVES THEREOF IN SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSTICS | 2008 |
|
RU2521228C2 |
| PHOTOSENSITISING COMPOSITIONS | 2010 |
|
RU2574019C2 |
| SEMI-SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS | 2010 |
|
RU2526803C2 |
| ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID AND ITS DERIVATIVES | 2005 |
|
RU2392266C2 |
| METHOD OF PHOTODYNAMIC THERAPY (PDT) OF BLADDER CANCER | 2016 |
|
RU2745194C2 |
| NEO-ADJUVANT THERAPY FOR BLADDER CANCER | 2016 |
|
RU2783177C2 |
